DEA’s National Prescription Drug Take Back Day: April 27, 2019

Transportation.Gov web banner

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

 

DEA's National Prescription Drug Take Back Day

The Drug Enforcement Administration (DEA) has scheduled another National Prescription Drug Take Back Day, to be held on Saturday April 27, 2019 from 10 a.m. to 2 p.m.

The Take Back Day aims to provide a safe, convenient, and responsible means of disposal, while also educating the general public about the potential for abuse of medications.  The Take Back Day provides an opportunity for Americans to prevent drug addiction and overdose deaths.

This is a great opportunity for those who missed previous events, or who have subsequently accumulated unwanted, unused prescription drugs, to dispose of those medications easily and safely.

For more information, including a Collection Site Locator, public service announcements, resources and treatment information, please visit DEA's website https://takebackday.dea.gov/.


U.S. Department of Transportation | 1200 New Jersey Avenue, SE | Washington DC 20590 | 202-385-HELP (4357) GovDelivery logo

DOT Publishes Drug Testing Rule

Transportation.Gov web banner

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

 

DOT Publishes Drug Testing Rule

Today, April 23, 2019, the Department of Transportation (DOT) published a final rule that makes minor technical corrections to the OST, FAA, FTA, and PHMSA regulations governing drug testing for safety-sensitive employees to ensure consistency with the recent amendments made to the Department of Transportation's regulation, "Procedures for Transportation Workplace Drug and Alcohol Testing Programs," which added requirements to test for oxycodone, oxymorphone, hydrocodone, and hydromorphone to DOT-regulated drug testing programs.  The changes to the Department's regulation make it necessary to refer to these substances, as well as the previously covered drugs morphine, 6-acetylmorphine, and codeine, by the more inclusive term "opioids," rather than "opiates."  This rule amends the term in the FAA, FTA, and PHMSA regulations to ensure that all DOT drug testing rules are consistent with one another and with the Mandatory Guidelines for Federal Workplace Drug Testing Programs.  In addition, this rule makes a conforming amendment to include the term "opioids" in the wording of the Department's annual information collection requirement and clarifications to section 40.26 and Appendix H regarding the requirement for employers to follow the Department's instructions for the annual information collection.

To learn more about this final rule, visit our web page at https://www.transportation.gov/odapc/frpubs.


U.S. Department of Transportation | 1200 New Jersey Avenue, SE | Washington DC 20590 | 202-385-HELP (4357) GovDelivery logo